Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
This study is currently recruiting participants.
Study NCT00231894. Last updated on December 4, 2008.
Information provided by Manhattan Psychiatric Center
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Schizophrenia
Insulin Resistance
Cognitive Impairment
Additional conditions recognized in this trial
Cognition Disorders
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Glucose Metabolism Disorders
Hyperinsulinism
Mental Disorders
Metabolic Diseases
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Pioglitazone
Life style diet group
placebo
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Manhattan Psychiatric Center
Back to top of Main Content